Registration of securities issued in business combination transactions

Stockholders??? Equity (Deficit) (Details)

v3.23.3
Stockholders’ Equity (Deficit) (Details)
1 Months Ended 2 Months Ended 6 Months Ended 12 Months Ended
Jun. 14, 2023
USD ($)
$ / shares
shares
Nov. 07, 2022
Oct. 04, 2022
$ / shares
shares
Sep. 28, 2022
Sep. 28, 2022
USD ($)
Sep. 23, 2022
USD ($)
shares
Jul. 05, 2022
USD ($)
$ / shares
shares
Sep. 28, 2022
USD ($)
Sep. 23, 2022
USD ($)
shares
Oct. 23, 2022
USD ($)
shares
Jun. 30, 2023
USD ($)
$ / shares
shares
Jul. 05, 2022
USD ($)
$ / shares
shares
Dec. 31, 2022
USD ($)
$ / shares
shares
Dec. 31, 2021
USD ($)
$ / shares
shares
Jan. 27, 2023
$ / shares
Oct. 05, 2022
$ / shares
Dec. 31, 2019
$ / shares
shares
Stockholders’ Equity (Deficit) (Details) [Line Items]                                  
Common stock, shares authorized                     150,000,000   150,000,000 150,000,000      
Common stock, par value (in Dollars per share) | $ / shares                     $ 0.0001   $ 0.0001 $ 0.0001      
Common stock voting rights   the Reverse Stock Split                 one   one        
Preferred stock, shares authorized                     5,000,000   5,000,000 5,000,000      
Preferred stock, par value (in Dollars per share) | $ / shares                     $ 0.0001   $ 0.0001 $ 0.0001      
Preferred stock, shares issued                     1   1 1      
Convertible redeemable preferred stock, description                         the 2022 Unit Offering including 43,478,261 Common Warrants exercisable for 2,173,913 shares of Common Stock and 2,173,913 Underwriter Warrants exercisable for 108,696 shares of Common Stock. In accordance with our policy, we assessed the warrants issued in connection with the 2022 Unit Offering and determined that there are no instances outside of the Company’s control that could require cash settlement. In addition, we determined that the warrants issued in connection with the 2022 Unit Offering do not meet the definition of a derivative as they are indexed to the Company’s Common Stock and they satisfy all of the additional qualifications to be classified within equity. Accordingly, the net proceeds of $9.2 million were recorded as: (i) an increase to Common Stock of $217 representing the issuance of 1,469,143 shares of Common Stock attributable to the Units and the issuance of 704,770 shares of Common Stock from the exercise of the Pre-funded Warrants, both at their par value of $0.0001 per share and (ii) an increase to Additional Paid-In Capital of $9.2 million        
Exchangeable shares                     33,438   3,294,574        
Preferred Stock, conversion ratio for each common stock                         20-for-one        
Aggregate value of exchangeable shares (in Dollars) | $                     $ 255,877   $ 180,647        
Exchangable shares, issued (in Dollars) | $                     1,672   1,180        
Exchangeable shares, outstanding (in Dollars) | $                     $ 252,224   $ 285,672        
Outstanding exchanged for shares                     12,611   14,284        
Aggregate purchase price (in Dollars) | $               $ 20,000,000 $ 2,700,000                
Sale of common stock                 118,629   2,282,609 2,282,609          
Exchangeable shares issued                         552,148        
Gross purchase price (in Dollars) | $                         $ 1,100,000        
Description of unit offering             (i) 29,382,861 units consisting of 1,469,143 shares of Common Stock together with Common Stock warrants (the “Common Warrants”) to purchase up to 1,469,143 shares of Common Stock (together, the “Units”) and (ii) 14,095,400 pre-funded units, consisting of 14,095,400 pre-funded warrants (“Pre-funded Warrants”) to purchase 704,770 shares of Common Stock, together with Common Warrants to purchase up to 704,770 shares of Common Stock (together, the “Pre-funded Units”). The Units were sold at a public offering price of $0.23 per unit and the Pre-funded Units were sold at a public offering price of $0.2299 per pre-funded unit.                    
Original conversion price (in Dollars per share) | $ / shares             $ 4.6       $ 0.37 $ 4.6     $ 0.88    
Convertible into shares of common stock per share (in Dollars per share) | $ / shares                               $ 3.518  
Underwriter warrants to purchase             108,696         108,696          
Original conversion price (in Dollars per share) | $ / shares                     $ 0.5   $ 4.6        
Proceeds from net (in Dollars) | $             $ 9,200,000                    
Warrants outstanding                     45,652,174   45,652,174        
Class of warrant or right expense or revenue recognized                     In connection with MTech’s initial public offering, MTech sold units consisting of one share of MTech’s common stock and one warrant of MTech (“MTech Public Warrant”). Each MTech Public Warrant entitled the holder to purchase one share of MTech’s common stock. Concurrently with MTech’s initial public offering, MTech sold additional units on a private offering basis. Each of these units consisted of one share of MTech’s common stock and one warrant of MTech (“MTech Private Warrant”).   initial public offering, MTech sold units consisting of one share of MTech’s common stock and one warrant of MTech (“MTech Public Warrant”). Each MTech Public Warrant entitled the holder to purchase one share of MTech’s common stock. Concurrently with MTech’s initial public offering, MTech sold additional units on a private offering basis. Each of these units consisted of one share of MTech’s common stock and one warrant of MTech (“MTech Private Warrant”)        
Warrant, conversion ratio for each common stock                         one-for-one        
Common warrants shares                     43,478,261   1        
Issued                       59,747,574        
Termination fee and related expenses (in Dollars) | $ $ 200,000                                
Description of unit offering             (i) 29,382,861 units consisting of 1,469,143 shares of Common Stock together with Common Stock warrants (the “Common Warrants”) to purchase up to 1,469,143 shares of Common Stock (together, the “Units”) and (ii) 14,095,400 pre-funded units, consisting of 14,095,400 pre-funded warrants (“Pre-funded Warrants”) to purchase 704,770 shares of Common Stock, together with Common Warrants to purchase up to 704,770 shares of Common Stock (together, the “Pre-funded Units”). The Units were sold at a public offering price of $0.23 per unit and the Pre-funded Units were sold at a public offering price of $0.2299 per pre-funded unit.                    
Common Stock [Member]                                  
Stockholders’ Equity (Deficit) (Details) [Line Items]                                  
Number of classes of stock                     1   1        
Exchangeable shares                         23,614        
Sale of common stock                         2,282,609        
Original conversion price (in Dollars per share) | $ / shares                     $ 0.37   $ 4.6        
Common warrants shares                         1       1
Common stock per share (in Dollars per share) | $ / shares                                 $ 230
Excess Stock, Shares Issued                         704,770        
Underwriter warrants to purchase                     2,173,913            
Warrant [Member]                                  
Stockholders’ Equity (Deficit) (Details) [Line Items]                                  
Warrants expire, term                         5 years        
Warrants outstanding                         20       20
Minimum [Member]                                  
Stockholders’ Equity (Deficit) (Details) [Line Items]                                  
Original conversion price (in Dollars per share) | $ / shares                     $ 1.2            
Maximum [Member]                                  
Stockholders’ Equity (Deficit) (Details) [Line Items]                                  
Original conversion price (in Dollars per share) | $ / shares                     4.75            
Pre Funded Warrants [Member]                                  
Stockholders’ Equity (Deficit) (Details) [Line Items]                                  
Original conversion price (in Dollars per share) | $ / shares             $ 0.002       0.002 $ 0.002          
Issued                         14,095,400        
Common Warrant [Member]                                  
Stockholders’ Equity (Deficit) (Details) [Line Items]                                  
Original conversion price (in Dollars per share) | $ / shares                     $ 0.37   $ 0.37 [1]   $ 0.88    
Common warrants shares                     2,173,913            
Issued                     [1]   43,478,261 [2]        
Underwriter Warrants [Member]                                  
Stockholders’ Equity (Deficit) (Details) [Line Items]                                  
Exchangeable shares                     108,696            
Original conversion price (in Dollars per share) | $ / shares                     $ 4.6   $ 0.37 [1]        
Issued                     [1]   2,173,913 [2]        
Effective date                     Jun. 29, 2022            
Underwriter Warrants [Member] | Minimum [Member]                                  
Stockholders’ Equity (Deficit) (Details) [Line Items]                                  
Original conversion price (in Dollars per share) | $ / shares                     $ 0.37         0.88  
Underwriter warrants to purchase                     108,696            
Underwriter Warrants [Member] | Maximum [Member]                                  
Stockholders’ Equity (Deficit) (Details) [Line Items]                                  
Original conversion price (in Dollars per share) | $ / shares                     $ 0.88            
A T M Program [Member]                                  
Stockholders’ Equity (Deficit) (Details) [Line Items]                                  
Aggregate purchase price (in Dollars) | $         $ 20,000,000 $ 800,000     $ 800,000       $ 25,000,000 $ 25,000,000      
Sale of common stock           90,809     90,808                
Sale of stock, description       (the “2022 ATM Program”) from time to time through AGP as the sales agent for which they will receive a commission of 3.0% of the gross proceeds. The 2022 ATM Program is currently limited to $3.5 million due to certain restrictions imposed by the registration statement underlying the offering (the “Baby Shelf Limitation”). Under the Baby Shelf Limitation, we may not offer Common Stock under the registration statement with a value of more than one-third of the aggregate market value of our Common Stock held by non-affiliates in any twelve-month period, so long as the aggregate market value of our Common Stock held by non-affiliates is less than $75.0 million. (the “2022 ATM Program”) from time to time through AGP as the sales agent for which they will receive a commission of 3.0% of the gross proceeds. The 2022 ATM Program is currently limited to less than $0.4 million due to certain restrictions imposed by the registration statement underlying the offering (the “Baby Shelf Limitation”). Under the Baby Shelf Limitation, we may not offer Common Stock under the registration statement with a value of more than one-third of the aggregate market value of our Common Stock held by non-affiliates in any twelve-month period, so long as the aggregate market value of our Common Stock held by non-affiliates is less than $75.0 million.                        
A T M Program [Member] | Common Stock [Member]                                  
Stockholders’ Equity (Deficit) (Details) [Line Items]                                  
Aggregate purchase price (in Dollars) | $                   $ 2,700,000              
Sale of common stock                   118,629              
Underwriters [Member]                                  
Stockholders’ Equity (Deficit) (Details) [Line Items]                                  
Original conversion price (in Dollars per share) | $ / shares                               3.518  
Private Placement [Member] | Common Stock [Member]                                  
Stockholders’ Equity (Deficit) (Details) [Line Items]                                  
Sale of common stock 1,000,000                                
Common stock per share (in Dollars per share) | $ / shares $ 0.5                                
Consideration Received Per Transaction (in Dollars) | $ $ 500,000                                
IPO [Member] | Underwriter Warrants [Member] | Maximum [Member]                                  
Stockholders’ Equity (Deficit) (Details) [Line Items]                                  
Original conversion price (in Dollars per share) | $ / shares                               $ 3.518  
Special Voting Preferred Stock [Member]                                  
Stockholders’ Equity (Deficit) (Details) [Line Items]                                  
Common stock voting rights                         one        
Preferred stock, shares authorized                     1   1 1      
Preferred stock, par value (in Dollars per share) | $ / shares                     $ 0.0001   $ 0.0001 $ 0.0001      
Preferred stock, shares issued                     1   1 1      
Preferred stock, par value (in Dollars) | $                         $ 0.0001        
Preferred stock, liquidation preference (in Dollars per share) | $ / shares                     $ 1   $ 1 $ 1      
Special voting preferred stock, description                     one            
Series A Preferred Stock [Member]                                  
Stockholders’ Equity (Deficit) (Details) [Line Items]                                  
Preferred stock, par value (in Dollars per share) | $ / shares     $ 0.0001                            
Preferred stock, shares issued     400,000                            
Series B Preferred Stock [Member]                                  
Stockholders’ Equity (Deficit) (Details) [Line Items]                                  
Preferred stock, par value (in Dollars per share) | $ / shares     $ 0.0001                            
Preferred stock, shares issued     100,000                            
Convertible Redeemable Preferred Stock [Member]                                  
Stockholders’ Equity (Deficit) (Details) [Line Items]                                  
Convertible redeemable preferred stock, description     (the “Series B Preferred Stock,” and together with the Series A Preferred Stock, the “Convertible Redeemable Preferred Stock”), at an offering price of $9.50 per share, representing a 5 percent original issue discount to the stated value of $10.00 per share, for gross proceeds of approximately $4.75 million in the aggregate, before the deduction of $0.4 million for fees and offering expenses of our financial advisor. We also incurred and paid approximately $0.1 million of other issue costs attributable to third-party professional and legal fees. The aggregate net proceeds (after deducting the fees and expenses of our financial advisor) together with the additional amount to provide for the 105 percent redemption premium, or $0.5 million, on the Convertible Redeemable Preferred Stock was deposited in an account with an escrow agent. The shares of the Convertible Redeemable Preferred Stock were convertible, at a conversion price of $0.25 per share (subject in certain circumstances to adjustments), into shares of our Common Stock, at the option of the holders and, in certain circumstances, by the Company.                   The holders of all of the Convertible Redeemable Preferred Stock redeemed their shares for cash at 105 percent of the stated value, or $10.50 per share, of such shares on November 9, 2022. Accordingly, we directed the escrow agent to pay $5.25 million on November 10, 2022 to the holders from the escrow account established upon the date of the Convertible Redeemable Preferred Stock offering. The amounts paid over the offering price upon redemption are considered “deemed” dividends and reported as a reduction of Additional paid-in capital in the consolidated statement of changes in stockholders’ equity (deficit).        
Exchangeable shares                     3,294,574            
Underwriter Warrants [Member]                                  
Stockholders’ Equity (Deficit) (Details) [Line Items]                                  
Warrants expire, term                         5 years        
Public warrant [Member]                                  
Stockholders’ Equity (Deficit) (Details) [Line Items]                                  
Exchangeable shares                                 290,690
2022 Unit Offering [Member]                                  
Stockholders’ Equity (Deficit) (Details) [Line Items]                                  
Original conversion price (in Dollars per share) | $ / shares                     $ 4.6            
Convertible Notes Amendment [Member]                                  
Stockholders’ Equity (Deficit) (Details) [Line Items]                                  
Proceeds deposited in restricted accounts (in Dollars) | $             $ 7,000,000         $ 7,000,000          
[1] In connection with the PIPE Investment, the exercise price of the Common Warrants and Underwriter Warrants was reduced from $0.88 per shares to $0.37 per share and are exercisable for a combined amount of 2,282,609 shares of Common Stock at $0.37 per share or a ratio of 20 warrants for one share of Common Stock.
[2] The Common Warrants and Underwriter Warrants are exercisable for a combined amount of 2,282,609 shares of Common Stock at $4.60 per share or a ratio of 20 warrants for one share of Common Stock.